![]() |
市場調查報告書
商品編碼
2016167
血栓除去裝置市場報告:按產品類型、應用、最終用戶和地區分類(2026-2034 年)Thrombectomy Devices Market Report by Product Type, Application, End User, and Region 2026-2034 |
||||||
2025年,全球血栓除去裝置市場規模達15億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到22億美元,2026年至2034年的複合年成長率(CAGR)為4.30%。目前,北美地區正引領全球市場成長,這主要歸因於老年族群中靜脈血栓栓塞症(VTE)發生率的上升。此外,外科醫師在進行影像導引手術時對血栓除去裝置的偏好日益增強,以及醫療基礎設施的不斷完善,也是推動市場成長的主要因素。
血栓除去裝置在替代終點指標方面具有諸多優勢,包括生物標記分析、梗塞面積縮小、ST段正常化以及血管造影術誘導的血栓溶解(TIMI)血流分級。這些裝置可最大限度地減少術中出血和血管壁損傷。因此,它們可用於治療靜脈、動脈和毛細血管中的血栓。此外,它們也用於治療肺動脈栓塞和周邊動脈疾病。目前,根據受累部位的不同,有各種尺寸和直徑的血栓切除裝置可供選擇。最常使用的血栓除去裝置手術包括球囊血栓切除術、外科血栓切除術和抽吸血栓切除術。
全球血栓除去裝置市場趨勢
世界衛生組織(WHO)指出,慢性病是全球死亡和殘疾的主要原因。繁忙的日程、久坐的生活方式、快餐消費量的增加以及吸煙和飲酒率的上升,都顯著加劇了這些疾病的患病率。這是推動全球血栓除去裝置市場成長的主要因素之一。此外,老年人口的成長、微創手術需求的增加以及各國醫療基礎設施的改善,也都在推動市場成長。同時,領先的製造商正在加大研發投入,以推出技術先進的血栓除去裝置,為市場帶來了良好的前景。此外,有利的醫療報銷政策以及外科醫生在進行影像導引手術時越來越傾向於使用這些器械,預計也將進一步促進市場成長。
市場區隔
本報告分析了全球血栓除去裝置市場各細分市場的關鍵趨勢,並提供了 2026 年至 2034 年的全球、區域和國家特定預測。該報告根據產品類型、應用和最終用戶對市場進行了細分。
按產品類型細分
按用途細分
按最終用戶細分
按地區分類
競爭格局
該報告還檢視了該行業的競爭格局,以及 Argon Medical Devices Inc.、Boston 主要企業 Corporation、Edwards Lifesciences Corporation、Johnson & Johnson、Medtronic Plc、Penumbra Inc.、Spectranetics Corporation(Koninklijke Philips NV)、 檢驗 Corporation、Teleflex Incorporated 和 Terumo Corporation 等主要公司的概況。
The global thrombectomy devices market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.30% during 2026-2034. North America currently dominates the global market, owing to the rising incidences of venous thromboembolism (VTE) among the geriatric population. Moreover, rising preferences for thrombectomy devices by surgeons to perform image-guided surgeries and continuous improvements in healthcare infrastructures are primarily propelling the market.
Thrombectomy devices offer numerous benefits in surrogate endpoints, such as biomarker analysis, infarct size reduction, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices minimize blood loss and damage caused to the vessel wall during a procedure. Consequently, they find application in treating blood clots present in veins, arteries and capillaries. They are also used to treat pulmonary embolism and peripheral arterial diseases. At present, they are widely available in different sizes and diameters, depending on the affected area. Some of the most frequently used thrombectomy devices procedures are balloon embolectomy, surgical embolectomy and aspiration embolectomy.
Global Thrombectomy Devices Market Trends
According to the World Health Organization (WHO), chronic diseases are the leading causes of death and disability around the world. Disease rates from these conditions are accelerating significantly on account of hectic schedules, sedentary lifestyles, rising consumption of fast food and the increasing number of individuals who smoke and consume alcohol. This represents one of the key factors propelling the growth of the thrombectomy devices market worldwide. Moreover, the growing geriatric population, along with the escalating demand for minimally invasive (MI) procedures and improving healthcare infrastructure in various countries, is also fueling the growth of the market. Furthermore, the leading manufacturers are increasing their investments in research and development (R&D) activities to introduce technologically advanced thrombectomy devices, which, in turn, is creating a positive outlook for the market. Besides this, favorable medical reimbursements and rising preference of these devices by surgeons for performing image-guided surgeries are anticipated to strengthen the market growth.
Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global thrombectomy devices market report, along with forecasts at the global, regional and country level from 2026-2034. The report has categorized the market based on product type, application and end user.
Breakup by Product Type
Breakup by Application
Breakup by End User
Breakup by Region
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation.